Evidence map›Paper›PMID 19996123›Full record

ArticleMolecular & cellular proteomics : MCP2010

Mutant prion protein expression is associated with an alteration of the Rab GDP dissociation inhibitor alpha (GDI)/Rab11 pathway.

Tania Massignan, Emiliano Biasini, Eliana Lauranzano, Pietro Veglianese, Mauro Pignataro, Luana Fioriti, David A Harris, Mario Salmona, Roberto Chiesa, Valentina Bonetto

Open access · hybridAbstract read
In one paragraph

Article in Molecular & cellular proteomics : MCP, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Lysosomal Quality Control in Prion Diseases.Molecular neurobiology · 2018
    Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Synaptic dysfunction in prion diseases: a trafficking problem?International journal of cell biology · 2013
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Tania MassignanDulbecco Telethon Institute (DTI) c/o Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
Emiliano Biasini
Eliana Lauranzano
Pietro Veglianese
Mauro Pignataro
Luana Fioriti
David A Harris
Mario Salmona
Roberto Chiesa
Valentina Bonetto
Mario Negri Institute for Pharmacological Research · ITDulbecco Telethon Institute · ITWashington University in St. Louis · US

Funding

MURINE TRANSGENIC MODELS OF PRION DISEASESR01NS040975 · NINDS · WASHINGTON UNIVERSITY · PI HARRIS, DAVID A · 2001 to 2015
$7.0M
Cellular Functions of the Prion ProteinR01NS052526 · NINDS · WASHINGTON UNIVERSITY · PI HARRIS, DAVID A · 2006 to 2010
$1.7M
NINDS NIH HHS NS040975NINDS NIH HHS NS052526NINDS NIH HHS R01 NS040975NINDS NIH HHS R01 NS052526Telethon TCR08002Telethon TCR08005
6 · The paper itself

Abstract

The prion protein (PrP) is a glycosylphosphatidylinositol-anchored membrane glycoprotein that plays a vital role in prion diseases, a class of fatal neurodegenerative disorders of humans and animals. Approximately 20% of human prion diseases display autosomal dominant inheritance and are linked to mutations in the PrP gene on chromosome 20. PrP mutations are thought to favor the conformational conversion of PrP into a misfolded isoform that causes disease by an unknown mechanism. The PrP mutation D178N/Met-129 is linked to fatal familial insomnia, which causes severe sleep abnormalities and autonomic dysfunction. We showed by immunoelectron microscopy that this mutant PrP accumulates abnormally in the endoplasmic reticulum and Golgi of transfected neuroblastoma N2a cells. To investigate the impact of intracellular PrP accumulation on cellular homeostasis, we did a two-dimensional gel-based differential proteomics analysis. We used wide range immobilized pH gradient strips, pH 4-7 and 6-11, to analyze a large number of proteins. We found changes in proteins involved in energy metabolism, redox regulation, and vesicular transport. Rab GDP dissociation inhibitor alpha (GDI) was one of the proteins that changed most. GDI regulates vesicular protein trafficking by acting on the activity of several Rab proteins. We found a specific reduction in the level of functional Rab11 in mutant PrP-expressing cells associated with impaired post-Golgi trafficking. Our data are consistent with a model by which mutant PrP induces overexpression of GDI, activating a cytotoxic feedback loop that leads to protein accumulation in the secretory pathway.

Indexed as

AnimalsEndoplasmic ReticulumGene ExpressionGolgi ApparatusGuanine Nucleotide Dissociation InhibitorsHumansMiceMutant ProteinsNeuronsPrionsProtein TransportProteomicsrab11 GTP-Binding Proteinsrab GTP-Binding ProteinsRNA, Small InterferingSecretory PathwayGDP dissociation inhibitor 1Guanine Nucleotide Dissociation InhibitorsMutant ProteinsPrionsrab11 GTP-Binding Proteinsrab GTP-Binding ProteinsRNA, Small Interfering

Identifiers

PMID19996123
PMCPMC2860234
OpenAlexW2107567986

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.